| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $85.1M | -18.3% |
| SG&A Expense | $26.4M | -7.4% |
| Operating Income | -$97.6M | +24.0% |
| Pre-tax Income | -$95.9M | +25.2% |
| Income Tax | $106K | -25.9% |
| Net Income | -$96.0M | +25.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $81.3M | -56.5% |
| Short-term Investments | $44.5M | +1035.3% |
| Current Assets | $133.5M | -34.7% |
| Total Assets | $146.7M | -37.7% |
| Current Liabilities | $33.1M | -15.0% |
| Total Liabilities | $42.8M | -15.5% |
| Stockholders' Equity | $103.9M | -43.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$79.4M | +31.4% |
| Capital Expenditures | $943K | +5.7% |
| Investing Cash Flow | -$26.3M | -970.1% |
| Financing Cash Flow | $164K | -99.8% |
| Free Cash Flow | -$80.3M | +31.1% |